ReviewThe journal of allergy and clinical immunology. In practice2019
Controversies in Drug Allergy: Drug Allergy Pathways.
Review in The journal of allergy and clinical immunology. In practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Accuracy of penicillin allergy diagnostic tests: A systematic review and meta-analysis.The Journal of allergy and clinical immunology · 2021Pooled it
- Cephalosporin use and patient outcomes following removal of penicillin-cephalosporin cross-reactivity alerts from the electronic health record.Antimicrobial agents and chemotherapy · 2026Observational
- Beta-lactam antibiotics administration among adult inpatients with a beta-lactam allergy label: incidence, predictors, and outcomes.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2024Article
- A new pathway for penicillin delabeling in Norway.The World Allergy Organization journal · 2023Article
- Delabeling, safety, and impact of β-lactam allergy testing: A systematic review.The journal of allergy and clinical immunology. Global · 2023Article
- Approach for delabeling beta-lactam allergy in children.Frontiers in allergy · 2023Review
- Immediate and Delayed Hypersensitivity Reactions to Beta-Lactam Antibiotics.Clinical reviews in allergy & immunology · 2022Review
- Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement.The World Allergy Organization journal · 2022Review
- Outcome of a de-labelling algorithm compared with results of penicillin (β-lactam) allergy testing.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2022Article
- Reconciling Allergy Information in the Electronic Health Record After a Drug Challenge Using Natural Language Processing.Frontiers in allergy · 2022Article
- The role of a clinical pharmacist in spurious Penicillin allergy: a narrative review.International journal of clinical pharmacy · 2021Review
- Association Between Removal of a Warning Against Cephalosporin Use in Patients With Penicillin Allergy and Antibiotic Prescribing.JAMA network open · 2021Article
- Penicillin Allergy Testing Is Cost-Saving: An Economic Evaluation Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021Article
- Allergy to penicillin and betalactam antibiotics.Einstein (Sao Paulo, Brazil) · 2021Article
- Penicillin allergy: a practical approach to assessment and prescribing.Australian prescriber · 2019Review
- Controversies in drug allergy: consensus documents from the world experts.The World Allergy Organization journal · 2018Article
- Important questions in drug allergy and hypersensitivity: consensus papers from the 2018 AAAAI/WAO international drug allergy symposium.The World Allergy Organization journal · 2018Article
- Clinical decision support improved allergy documentation of antibiotic test dose results.The journal of allergy and clinical immunology. In practiceArticle
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
Abstract
Drug allergy pathways are standardized approaches for patients reporting prior drug allergies with the aim of quality improvement and promotion of antibiotic stewardship. At the International Drug Allergy Symposium during the 2018 American Academy of Allergy, Asthma, and Immunology/World Allergy Organization Joint Congress in Orlando, Florida, drug allergy pathways were discussed from international perspectives with a focus on beta-lactam allergy pathways and pragmatic approaches for acute care hospitals. In this expert consensus document, we review current pathways, and detail important considerations in devising, implementing, and evaluating beta-lactam allergy pathways for hospitalized patients. We describe the key patient and institutional factors that must be considered in risk stratification, the central feature of pathway design. We detail shared obstacles to widespread beta-lactam allergy pathway implementation and identify potential solutions to address these challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.